| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.05B | +12.2% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 22.5% | Net margin -42.7% |
| Revenue Q/Q | -44.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.04B | 77.5% |
| R&D | ¥0.00B | 10.3% |
| SG&A | ¥0.02B | 32.9% |
| Tax & other | ¥0.00B | 0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华大基因 ・ 英科医疗 ・ 中科信息 ・ 电连技术 ・ 隆盛科技 ・ 英搏尔 ・ 朗新科技 ・ 海特生物 ・ 中石科技 ・ 艾德生物 ・ 智动力 ・ 赛意信息
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies